SG11201800698VA - Hydroxytriazine compound and medical use thereof - Google Patents

Hydroxytriazine compound and medical use thereof

Info

Publication number: SG11201800698VA
Authority: SG; Singapore
Prior art keywords: medical use; hydroxytriazine; compound; hydroxytriazine compound; medical
Prior art date: 2015-08-17

Application number

SG11201800698VA

Inventor

Ikuo Mitani

Yutaro Hirono

Masaki Yamashita

Original Assignee

Japan Tobacco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-08-17

Filing date

2016-08-16

Publication date

2018-03-28

2016-08-16 Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc

2018-03-28 Publication of SG11201800698VA publication Critical patent/SG11201800698VA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

SG11201800698VA 2015-08-17 2016-08-16 Hydroxytriazine compound and medical use thereof SG11201800698VA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2015160284		2015-08-17
PCT/JP2016/073879 WO2017030115A1 (en)	2015-08-17	2016-08-16	Hydroxytriazine compound and medical use thereof

Publications (1)

Publication Number	Publication Date
SG11201800698VA true SG11201800698VA (en)	2018-03-28

Family

ID=58052084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201800698VA SG11201800698VA (en)	2015-08-17	2016-08-16	Hydroxytriazine compound and medical use thereof

Country Status (19)

Country	Link
US (3)	US20170057943A1 (en)
EP (2)	EP4046991A1 (en)
JP (4)	JP2017039714A (en)
KR (1)	KR20180037270A (en)
CN (1)	CN108137515B (en)
AR (1)	AR105711A1 (en)
AU (1)	AU2016309337B2 (en)
BR (1)	BR112018001809A2 (en)
CA (1)	CA2992410A1 (en)
CL (1)	CL2018000430A1 (en)
CO (1)	CO2018002516A2 (en)
IL (1)	IL257559B (en)
MX (1)	MX375283B (en)
PE (1)	PE20180951A1 (en)
PH (1)	PH12018500181A1 (en)
SG (1)	SG11201800698VA (en)
TW (1)	TWI704139B (en)
WO (1)	WO2017030115A1 (en)
ZA (1)	ZA201801134B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20170057943A1 (en) *	2015-08-17	2017-03-02	Japan Tobacco Inc.	Hydroxytriazine compounds and pharmaceutical use thereof
US10710967B2 (en) *	2015-10-29	2020-07-14	Aska Pharmaceutical Co., Ltd.	Pyrimidine derivative
RU2648181C1 (en) *	2017-05-25	2018-03-22	Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации	Method for treatment of neurorethynopathy that is caused by heavy preeclampsia
WO2019002183A1 (en) *	2017-06-26	2019-01-03	Merck Patent Gmbh	Method for producing substituted nitrogen-containing heterocycles
TW202409037A (en) *	2022-07-06	2024-03-01	日商Ａｓｋａ製藥股份有限公司	Pyrimidine derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2138488A1 (en) *	2008-06-26	2009-12-30	sanofi-aventis	4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
GB2463788B (en) *	2008-09-29	2010-12-15	Amira Pharmaceuticals Inc	Heteroaryl antagonists of prostaglandin D2 receptors
CN101747282A (en) *	2008-12-10	2010-06-23	上海特化医药科技有限公司	Phenyl pyrimidone compounds, pharmaceutical compositions and preparation methods and uses thereof
US8952150B2 (en) *	2009-09-23	2015-02-10	Albert Einstein College Of Medicine Of Yeshiva University	Prostaglandin transporter inhibitors and uses thereof
AR086254A1 (en) *	2011-05-26	2013-11-27	Lilly Co Eli	USEFUL IMIDAZOL DERIVATIVES FOR THE TREATMENT OF ARTHRITIS
TWI568722B (en) *	2012-06-15	2017-02-01	葛蘭馬克製藥公司	Triazolone compounds as mpges-1 inhibitors
WO2015059618A1 (en) *	2013-10-22	2015-04-30	Glenmark Pharmaceuticals S.A.	SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS
TWI651310B (en) *	2014-02-20	2019-02-21	日商日本煙草產業股份有限公司	Triterpenoids and their medical use
US20170057943A1 (en) *	2015-08-17	2017-03-02	Japan Tobacco Inc.	Hydroxytriazine compounds and pharmaceutical use thereof

2016
- 2016-08-16 US US15/237,763 patent/US20170057943A1/en not_active Abandoned
- 2016-08-16 MX MX2018002044A patent/MX375283B/en active IP Right Grant
- 2016-08-16 AR ARP160102503A patent/AR105711A1/en unknown
- 2016-08-16 CN CN201680060597.6A patent/CN108137515B/en active Active
- 2016-08-16 EP EP22162814.2A patent/EP4046991A1/en active Pending
- 2016-08-16 SG SG11201800698VA patent/SG11201800698VA/en unknown
- 2016-08-16 CA CA2992410A patent/CA2992410A1/en active Pending
- 2016-08-16 TW TW105126071A patent/TWI704139B/en active
- 2016-08-16 WO PCT/JP2016/073879 patent/WO2017030115A1/en active Application Filing
- 2016-08-16 AU AU2016309337A patent/AU2016309337B2/en not_active Ceased
- 2016-08-16 PE PE2018000185A patent/PE20180951A1/en unknown
- 2016-08-16 BR BR112018001809-0A patent/BR112018001809A2/en not_active Application Discontinuation
- 2016-08-16 EP EP16837104.5A patent/EP3339296A4/en not_active Withdrawn
- 2016-08-16 KR KR1020187007349A patent/KR20180037270A/en not_active Ceased
- 2016-08-16 JP JP2016159454A patent/JP2017039714A/en not_active Ceased
2018
- 2018-01-24 PH PH12018500181A patent/PH12018500181A1/en unknown
- 2018-02-15 IL IL257559A patent/IL257559B/en unknown
- 2018-02-16 CL CL2018000430A patent/CL2018000430A1/en unknown
- 2018-02-19 ZA ZA2018/01134A patent/ZA201801134B/en unknown
- 2018-03-12 CO CONC2018/0002516A patent/CO2018002516A2/en unknown
2020
- 2020-03-03 US US16/807,719 patent/US20210024486A1/en not_active Abandoned
- 2020-09-04 JP JP2020148973A patent/JP2020193235A/en not_active Ceased
2022
- 2022-08-12 JP JP2022128590A patent/JP2022163169A/en active Pending
2023
- 2023-02-24 US US18/114,043 patent/US20240076278A1/en active Pending
- 2023-12-08 JP JP2023207429A patent/JP7640658B2/en active Active

Also Published As

Publication number	Publication date
JP2024019449A (en)	2024-02-09
US20240076278A1 (en)	2024-03-07
MX375283B (en)	2025-03-06
RU2018109220A (en)	2019-09-19
EP3339296A1 (en)	2018-06-27
JP7640658B2 (en)	2025-03-05
JP2017039714A (en)	2017-02-23
JP2020193235A (en)	2020-12-03
TWI704139B (en)	2020-09-11
AR105711A1 (en)	2017-11-01
CL2018000430A1 (en)	2018-08-03
RU2018109220A3 (en)	2019-11-15
EP3339296A4 (en)	2019-01-23
IL257559A (en)	2018-04-30
MX2018002044A (en)	2018-04-13
PH12018500181A1 (en)	2018-07-30
CN108137515A (en)	2018-06-08
US20210024486A1 (en)	2021-01-28
US20170057943A1 (en)	2017-03-02
CA2992410A1 (en)	2017-02-23
ZA201801134B (en)	2019-07-31
AU2016309337A1 (en)	2018-02-01
CO2018002516A2 (en)	2018-05-31
IL257559B (en)	2021-07-29
JP2022163169A (en)	2022-10-25
BR112018001809A2 (en)	2018-09-18
KR20180037270A (en)	2018-04-11
EP4046991A1 (en)	2022-08-24
PE20180951A1 (en)	2018-06-11
WO2017030115A1 (en)	2017-02-23
AU2016309337B2 (en)	2021-03-04
CN108137515B (en)	2021-07-06
TW201718524A (en)	2017-06-01

Publication	Publication Date	Title
HK1247614A1 (en)	2018-09-28	Therapeutic compounds and uses thereof
HK1249103B (en)	2020-02-07	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
HRP20182134T1 (en)	2019-02-08	Triazine compound and use thereof for medical purposes
SG11201707816PA (en)	2017-10-30	Patient interface and aspects thereof
IL283335B (en)	2022-04-01	Dihydropyrimidin-2-one compounds and medical use thereof
HK1248697A1 (en)	2018-10-19	Therapeutic compounds and uses thereof
ZA201802256B (en)	2019-01-30	Compounds and therapeutic uses thereof
ZA201801134B (en)	2019-07-31	Hydroxytriazine compound and medical use thereof
IL250729A0 (en)	2017-04-30	Pyrazolothiazole compound and medicine comprising same
PT3129398T (en)	2019-09-06	New medical agents and uses thereof
IL265617B (en)	2022-01-01	1-phenylpropanone compounds and use thereof
GB201713975D0 (en)	2017-10-18	Medical use
GB2545167B (en)	2022-02-16	Cloches and use thereof
GB201514770D0 (en)	2015-09-30	Compounds and their use
GB201504770D0 (en)	2015-05-06	Medical devices and methods